Sabuero, Datuoto N.
HRN: 15-54-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2024
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
08/18/2024
08/21/2024
PO
3 Ml
Q12
T/C LEPTOSPIROSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes